Assessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014–2017 BRFSS.

The purpose of this study was to assess gender identity differences in CVD risk and CVD conditions among adults in the U.S. Using data from the 2014–2017 BRFSS we compared CVD risk and CVD conditions in gender minorities (transgender men, transgender women and gender nonconforming persons) to both cisgender men and women. The sample consisted of 662,903 participants. Transgender women (AOR 1.34, 95% CI 1.05–1.72) and transgender men (AOR 1.54, 95% CI 1.07–2.24) were more likely to be overweight than cisgender women. Compared to cisgender women, transgender women reported higher rates of diabetes (AOR 1.45, 95% CI 1.05–1.99), angina/coronary heart disease (AOR 1.90, 95% CI 1.34–2.68), stroke (AOR 1.88, 95% CI 1.16–3.03), and myocardial infarction (AOR 2.98, 95% CI 2.14–4.17). Gender nonconforming participants (AOR 2.68, 95% CI 1.14–6.30) reported higher odds of myocardial infarction than cisgender women. Transgender women also had higher rates of reporting any CVD than cisgender men (AOR 1.38, 95% CI 1.01–1.88). There is a need to elucidate the cardiovascular effects of minority stressors and gender affirming therapy in this population. More research focused on CVD prevention and management in gender minorities is recommended. [ABSTRACT FROM AUTHOR]